Written by Stuart Stevens | Sunday, 24 June 2007 | There are 0 comments
Those of you who read Ukmedix News on Tamiflu on a regular basis will know that we had earlier this year reported about the concerns that the Japanese government and health authorities had about the Tamiflu influenza drug. There were a few reports that Japanese teenagers who had been given the flu medication were hallucinating and even jumping out of buildings.

Japan is one of the largest markets in the world for Tamiflu and it is prescribed very often even for mild cases of flu. Overall Tamiflu has been prescribed to 45 million men and women over the world and has been selling for eight years now. The Japanese use of Tamiflu is 70% of the complete global usage and thus it was likely that if there were to be any issues with Tamiflu they would be experienced in Japan.
The Ministry of Health in Japan recently announced that they do not have any evidence that Tamiflu causes any mental problems whatsoever, however just to be extra safe they said they would conduct more research along with the drug’s manufacturer Roche Pharmaceutical so that they could be even surer that the drug was not dangerous.
When you consider the millions and millions of individuals who have used the Tamiflu influenza drug and then you consider the very small numbers of people who have supposedly experienced psychological side effects the risk is almost completely negligible. It is also worth noting that people who are suffering from flu can in some rare cases experience hallucination and temporary psychological problems as a side effect of the influenza.
Tamiflu is considered to be (by the World Health Organisation) the world’s most effective drug for combating the deadly H5N1 bird flu virus that has killed almost 200 people worldwide. The World Health Organisation has advised governments to stock up with Tamiflu so that they can be ready to meet a bird flu pandemic should one materialise.
